Biosensors names Evercore Asia as adviser for Citic takeover offer
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THE independent directors of Biosensors International Group has appointed Evercore Asia (Singapore) to provide independent financial advice on a takeover offer by a unit of Citic Group.
Citic Private Equity Funds Management Co is offering 84 Singapore cents per share to privatise Biosensors, a maker of coronary stents and other medical devices. The offer price was at a 24 per cent premium to Citic's pre-deal price of about 68 Singapore cents.
Biosensors stock traded at 80 Singapore cents as at 9.45am on Friday.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
